[Systemic functions of the brain after administration of protein synthesis blockers and oligopeptides].
D000818:Animals; D001375:Azaguanine / Q000008:administration & dosage / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology*; D001920:Bradykinin / Q000008:administration & dosage / Q000494:pharmacology; D002415:Cats; D003513:Cycloheximide / Q000008:administration & dosage / Q000494:pharmacology*; D004743:Enkephalin, Leucine / Q000008:administration & dosage / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects / Q000502:physiology*; D008960:Models, Psychological; D009042:Motivation; D009419:Nerve Tissue Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D009842:Oligopeptides / Q000008:administration & dosage / Q000494:pharmacology*; D010418:Pentagastrin / Q000494:pharmacology; D011691:Puromycin / Q000008:administration & dosage / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats
D009419:Nerve Tissue Proteins; D009842:Oligopeptides; D011691:Puromycin; D004743:Enkephalin, Leucine; D003513:Cycloheximide; D010418:Pentagastrin; D001375:Azaguanine; D001920:Bradykinin
Sistemnye funktsii mozga v usloviiakh deĭstviia blokatorov sinteza belka i oligopeptidov.